Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)

Series
Procedures on upper gastrointestinal tract
Status
Published
Date
Number of report
021

Ask the expert

(we accept only company emails)

Report presents summary of reimbursement situation for procedures to treat gastro-esophageal reflux disease (GERD) in European countries.           

Four minimally invasive procedures are considered in the report:

  • Radiofrequency ablation
  • Endoscopic plication and suturing
  • Injection of bulking agents

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for endoluminal treatment of gastro-esophageal reflux disease (GERD) include:

Radiofrequency ablation

  • Mederi Therapeutics (Stretta System)
  • Medtronic (Barrx radiofrequency ablation system)

Endoscopic plication and suturing

  • Apollo Endosurgery (OverStitch Endoscopic Suturing System)
  • C.R.Bard (EndoCinch device)
  • Endogastric Solutions (EsophyX System)
  • Medigus (SRS Endoscopic Stapling System)
  • Medtronic (Gatekeeper Reflux Repair System)

Injection of bulking agents

  • Carbon Medical Technologies (Durasphere GR)

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants

  • Boston Scientific (Enteryx Device)
  • Medtronic (Gatekeeper Reflux Repair System)

Table of content is not available at the moment.

18

Jan 2022

In December 2021, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (endobronchial nerve ablation for chronic obstructive pulmonary disease and transanal total mesorectal excision for rectal cancer), two new Medical Technologies Guidance (ClearGuard HD antimicrobial barrier caps, and Endo-SPONGE for treating low rectal anastomotic leak), and one new Medtech Innovation Briefings (FreeO2 automatic oxygen titration). Also, one new clinical guideline was published, and five were updated.

Read more

14

Jan 2022

On December 9, 2021, the Danish Treatment Council (Behandlingsråd), during its meeting, approved three topics selected for developing the so-called major analyses (større analyser) in 2022. The approved topics include handheld focused ultrasound in emergency medicine, artificial intelligence (AI) as decision support for colonoscopy, and intelligent/high-tech beds for use in intensive care units.

Read more

29

Dec 2021

In early December 2021, the Danish Health Authority (Sundhedsdatastyrelsen) has published DRG tariffs, as well as psychiatric and rehabilitation rates for 2022. Later on, in mid-December 2021, the DRG tariff system (Takstsystem) guide for 2022 was also published. Among other changes, seven new DRGs, specifically in ENT, endoscopy, obstetrics, and gynecology fields, were introduced.

Read more

27

Dec 2021

On December 17, 2021, NHS Digital released HRG4+ Consultation Grouper for 2022/23. This release is used to support the NHS England and Improvement consultation process for the 2022/23 National Tariff Payment System. In general, there are significant changes in base HRG design. A total of 120 new HRGs were created, multiple HRGs were removed, and the grouping logic was updated significantly. This Consultation Grouper will be superseded by the 2022/23 Local Payment Grouper in March 2022, for use from April 01, 2022.

Read more

22

Dec 2021

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 20520 of November 22, 2021, Tuscany Regional Healthcare has published assessments of seventeen medical devices of various therapeutic areas, including devices belonging to neurology, as well as gastrointestinal, urology, cardiovascular, orthopedics, peripheral vascular, and other fields of care.

Read more
(we accept only company emails)